Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Cash Flows

v3.8.0.1
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Cash flows from operating activities:    
Net loss $ (4,130,000) $ (13,993,000)
Less: loss on discontinued operations, net of taxes of $0 (Note 8) (592,000) (730,000)
Loss from continuing operations (3,538,000) (13,263,000)
Adjustments to reconcile net loss from continuing operations to cash provided by operating activities:    
Depreciation and amortization 3,803,000 4,165,000
Amortization of debt issuance/discount costs 36,000 173,000
Deferred tax benefit (668,000) (3,062,000)
Provision for (recovery of) bad debt reserves 462,000 (314,000)
(Gain) loss on disposal of property and equipment (12,000) 2,000
Impairment loss on tangible assets 672,000 1,816,000
Impairment loss on intangible assets 8,288,000
Issuance of common stock for services 225,000 238,000
Stock-based compensation 144,000 98,000
Changes in operating assets and liabilities of continuing operations:    
Restricted cash 35,000
Accounts receivable 515,000 1,070,000
Unbilled receivables (1,589,000) 2,134,000
Prepaid expenses, inventories and other assets (54,000) 2,870,000
Accounts payable, accrued expenses and unearned revenue 1,093,000 (3,187,000)
Cash provided by continuing operations 1,089,000 1,063,000
Cash used in discontinued operations (647,000) (959,000)
Cash provided by operating activities 442,000 104,000
Cash flows from investing activities:    
Purchases of property and equipment (439,000) (436,000)
Proceeds from sale of property and equipment 30,000 44,000
Proceeds from /(payment to) finite risk sinking fund 5,811,000 (107,000)
Cash provided by (used in) investing activities of continuing operations 5,402,000 (499,000)
Cash provided by investing activities of discontinued operations 69,000 84,000
Cash provided by (used in) investing activities 5,471,000 (415,000)
Cash flows from financing activities:    
Borrowing on revolving credit 45,163,000 57,976,000
Repayments of revolving credit borrowings (48,966,000) (56,522,000)
Principal repayments of long term debt (1,219,000) (1,508,000)
Principal repayments of long term debt - related party (1,000,000)
Payment of debt issuance costs (122,000)
Proceeds from issuance of common stock upon exercise of warrants 156,000
Release of proceeds for stock subscription for Perma-Fix Medical S.A. previously held in escrow 64,000
Cash used in financing activities of continuing operations (5,022,000) (956,000)
Effect of exchange rate changes on cash 9,000 (5,000)
Increase (decrease) in cash 900,000 (1,272,000)
Cash at beginning of period 163,000 1,435,000
Cash at end of period 1,063,000 163,000
Supplemental disclosure:    
Interest paid 318,000 424,000
Income taxes paid 58,000 41,000
Non-cash investing and financing activities:    
Equipment purchase subject to capital lease $ 196,000